Systematic Review with Meta-Analysis: Lactobacillus reuteri DSM 17938 for Treating Acute Gastroenteritis in Children. An Update

2019-11-14
Meta-Analysis
Nutrients 11(11)
- B. Patro-Gołąb
- H. Szajewska

PubMed: 31739457
DOI: 10.3390/nu11112762

5 Insights on

Reduced Stool Volume

High evidence

None of them evaluated stool volume.

Effect: Neutral
Effect size: Small
Significant: No

Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: improvement in symptoms and bowel habit in functional constipation.

2018-01-29
RCT · n = 56
Beneficial Microbes 9(1)
- G. Riezzo
- A. Orlando
- B. D’Attoma
- M. Linsalata
- M. Martulli
- F. Russo

PubMed: 29022390
DOI: 10.3920/BM2017.0049

10 Insights on

Reduced Stool Volume

High evidence

the beneficial effect of LR DSM 17938 compared to placebo was significantly evident for symptoms related to gas content and dysbiosis (abdominal discomfort, pain and bloating), incomplete defecation and helps for defecation (P<0.05)

Effect: Beneficial
Effect size: Small
Significant: Yes
Dose: 4×10^8 cfu (induction, days 1-15), then 2×10^8 cfu (maintenance, days 16-105)